Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Alphamab (Australia) Co Pty Ltd.
Scientific Title
An Open-Label, Multi-center, Dose-Escalation Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics and Immunogenicity of KN046 in Subjects With Advanced Solid Tumors